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Measurin
change.
The experts explain what you
need to know about the new
method for reporting HbAk.
GEORGE BARKER,
DR MARK0 $ SOEPHAA0,,IAN GOODALL,
ElIZABETH ODERSTELLER AND DR GRAHAM JONES
ACHANGE
in the
reporting of HbAi, is
being adopted glob-
ally, including in Aus-
tralia.
It's anticipated that this
change will, among other
things, make it easier for doc-
tors to educate their patients
about the importance of gly-
caemic control. However, to
understand how this change
will help in practice, it's useful
to firstly understand what
HbAic is and to know some-
thing of the history of how
laboratories have measured
the flbAi, assay.
What is HbAlc?
Glycated haemoglobin is
formed by the binding of glu-
cose to the protein component
of haemoglobin in red blood
cells. The most common of
these glycated haemoglobins is
haemoglobin Alc ( HbAk).
The HbA,, result reflects the
patient's glycaemic control
over the 120-day lifespan of
red blood cells. The result is
time weighted with 50% of
the HbAk result reflecting the
glycaemic control in the
month prior to specimen col-
lection. The remaining 50%
reflects the two month period
from one to three months
prior to specimen collection.
Assays over lime
In the 1970s, a relationship
between long-term diabetes
complications and glycated
haemoglobins was identified.
The process of glycation was
found to occur slowly, mean-
ing that acute fluctuations in
blood glucose levels would not
impact significantly on the
HbA k result.
From the late 1970s to the
early 1980s, HbA, assays
took several days to perform
in the laboratory. A range of
other glycated fractions were
measured as well as HbAi,
and analysers were not very
precise, leading to significant
interlaboratory variation.
By the mid-to-late 1980s,
the HbAk assay was increas-
ingly used in the routine mon-
itoring of glycaemic control.
However, standardisation of
flbAic assays was rarely per-
formed and the same blood
sample would give very differ-
ent results when analysed by
different laboratories.
There was a global recogni-
tion of the need for different
laboratories to use a standard-
ised reference method.
Between 1983 and 1993,
the landmark Diabetes Con-
trol and Complications Trial
(DCCT) was conducted in the
US. This trial highlighted the
importance of the HbAk test
as the 'gold standard' marker
of diabetes control particu-
larly in relation to the reduc-
tion in diabetes complications
in patients with type 1 dia-
betes.
In the trial, all HbA, assays
were performed in one central
laboratory using a single
method.
Following the success of this
trial, the National Glycohemo-
globin Standardization Pro-
gram (NGSP) was established
in the US in 1996. The meas-
urement system used to per-
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form all the HbA, assays in
the DCCT central laboratory
was chosen as the NGSP refer-
ence method in the US; this
system was subsequently
adopted for use in Australia
and many other countries.
However, Japan and
Sweden developed separate
national systems. Clearly there
was a need for an international
standardisation program.
International reference
system
To address the lack of stan-
dardisation between countries,
the International Federation of
Clinical Chemistry (1FCC)
spent more than a decade
developing an international
reference system for Hb
analysis.
This reference system is
consistent with modern analy-
sers, which measure HbA,
more precisely than the
DCCT method, which meas-
ured other glycated fractions
as well as HbAl, and there-
fore overestimated the true
MA, value.
In 2007, there was interna-
tional agreement that HbAl,
test results should be stan-
dardised worldwide using the
IFCC reference system with
results reported in a different
unit.
All manufacturers now cal-
ibrate HbAle analysers using
the IFCC reference system
and all HbAl, methods used
in Australia are now stan-
dardised using this system.
The new HbA,, result has a
very different number value
and is reported in a unit
known as mmol/mol stated
as millimoles per mole (table
1).
For example 6% in the 'old'
DCCT unit is equivalent to 42
mmol/mol in the 'new' IFCC
unit.
The numbers from the
two systems can be con-
verted as follows:
HbA, (mmol/mol)
10.93 x HbA, (%) -23.50
HbAl, (°/0) = HbA,,
(mmol/mol) x 0.091 + 2.15
A calculator that quickly
There was a
global recognition
of the need
for different
laboratories to use
a standardised
reference method.
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allows you to convert the old
to new units is available at
the Quality Assurance for
Aboriginal and Torres Strait
Islander Medical Services
website (wvvw.qaams.org.au).
There's also an easier way
to convert the old reporting
method to the new that
works for HbA, (DCCT)
results in whole numbers
from 4% to 14%. Let's call
it the 'minus two minus two'
rule.
For example, for an
HbA,, of 7.0%, minus 2
from 7 = 5, and then minus
2 from 5 = 3, giving a result
of 53 mmol/mol.
Why change?
The new reporting method
is in keeping with the recent
international consensus and
is a contemporary and sci-
entifically valid measure of
HbA,,
International standardisa-
tion was needed because:
Patients and clinicians
need the most accurate
measure of HbA,, to assess
glycaemic control.
Diabetes centres and facili-
ties are often assessed on
the basis of patients
achieving HbA, targets
and therefore we need to
be able to measure these as
accurately as possible.
Certain diabetes medica-
tions can only be pre-
scribed on the basis of the
patient's HbA,, result.
There is now also a move
internationally to employ
HbA,, measurements as a
tool for diagnosing dia-
betes.
While there is no change
in the performance of the
current assays, the new stan-
dardisation allows for future
improvement to ensure the
highest quality result.
The change will reduce
confusion associated with
the current reporting system.
In practice, many patients
have assumed that the
HbAl, result is an average
of the blood glucose levels
obtained on their blood glu-
cose meters, namely that an
HbA,, of "7" means their
average blood glucose is
7mmol/L. This is clearly
incorrect.
Further, the use of "%"
units can make some signifi-
cant changes seem trivial, in
that a change of HbA, of
1% may appear insignifi-
cant.
The new IFCC system
reduces any confusion asso-
ciated with the closeness in
numerical value between the
HbAl, and the blood glu-
cose level.
Further, the number
values reported in the new
system are larger, making
variations in HbA,, results
over time appear more sig-
nificant.
Additionally, the relation-
ship with average blood glu-
cose is more closely aligned
halving the glucose will
lead to halving of the
HbA,.
This should make it easier
for doctors and other health
professionals involved in
diabetes care to help their
patients understand the sig-
nificance and difference of
the results obtained by both
methods.
This change is
similar to the
introduction
of the metric
system.
back
Ref: 123200656Copyright Agency Ltd (CAL) licenced copy
Australian Doctor
18-Nov-2011
Page: 33
General News
Market: National
Circulation: 20614
Type: Magazines Lifestyle
Size: 1922.95 sq.cms
----F--
Page 2 of 4
Archived at Flinders University: dspace.flinders.edu.au
What is happening
overseas?
A number of countries are
already reporting the new
units. These countries
include France, Denmark,
Japan, New Zealand, UK,
Germany, Holland, Italy and
Sweden.
A small number of coun-
tries, including the US and
Canada, have chosen not to
introduce the new units at
this time.
What is happening in
Australia?
The HbA, Reporting Unit
Working Party (HbA,
RWP) convened with repre-
sentation from the Aus-
tralasian Association of
Clinical Biochemists, the
Australian Diabetes Educa-
tors Association, the Aus-
tralian Diabetes Society and
the Royal College of Pathol-
ogists of Australasia. It
released a position statement
addressing this change ear-
lier this year.
In short, the HbA, work-
ing party recommended that
for two years from July
2011 to July 2013, HbA,
results in Australia should
be reported in both percent-
age units (NGSP) and
mmol/mol (IFCC), for
example, HbA, 6.0%
(NGSP); HbA, 42
mmol/mol (IFCC).
This will allow time to
implement the new report-
ing units slowly and provide
opportunities to develop
and disseminate educational
information about the
change to doctors, diabetes
health professionals and
patients.
After the two-year period
expires, only the new IFCC
units will be reported.
How have the goals
changed?
The reference interval for
patients without diabetes
using the new system will be
20-42 mmoUmol (equivalent
to 4.0-6.0% in the old
units).
The target range for adults
with diabetes should still be
individualised with a recom-
mended target HbA, level
less than or equal to
42mmol/mol (6.0%) in some
people, or up to
64mmol/mol (8.0%) in
others. However, for most it
will be less than
53mmol/mol (<7.0%).
HbA, targets for children
and adolescents with type 1
diabetes are less than
59mmol/mol (<7.5%) and
with type 2 diabetes are less
than 53mmoUL (<7.0 %).
What is the eAG?
In the current literature, you
may also see reference to the
term 'estimated average glu-
cose value' or eAG.
The eAG is a further esti-
mate of long-term glucose
control. The evidence for
reporting eAG has been
based on a small study
known as the ADAG study.
ADAG is an acronym for 'an
HbA, -derived average glu-
cose'. The purpose of the
study was to attempt to
define a relationship between
HbAlc and self-managed
blood glucose results.
The HbAi, RWP does not
endorse the routine report-
ing of the eAG and most
other countries have also
resolved not to report the
eAG, with the exception of
the US and Denmark.
For example, the Ameri-
can Diabetes Association
and the American Associa-
tion for Clinical Chemistry
believe that the reporting of
the HbA1c result with an
eAG result is justified when
a clinician orders the HbAl,
test.
While it is acknowledged
some Australian clinicians
will choose to use the eAG
as an educational tool, they
should be aware of its limita-
tions as well as its benefits.
It is suggested that report-
ing of eAG would make it
easier for patients with dia-
betes to understand their
results, as they directly relate
to their own blood glucose
levels obtained from their
blood glucose meter.
However, blood glucose
levels measured by a blood
glucose meter vary consider-
ably during the day. So
although the units are the
same, the eAG gives no indi-
cation of a patient's daily
range of glucose values.
Further, there is consider-
able controversy about the
strength of this evidence for
use of this surrogate meas-
ure from the ADAG study
with concern, among other
things, about the relatively
small, selected population
studied.
What can you do?
This change is similar to the
introduction of the metric
system. It will only work if
all participants in diabetes
management actively change
their ways. Just as laborato-
ries will report in the new
units, doctors and diabetes
educators should use the
new units in discussions with
patients and in correspon-
dence and other communi-
cation.
The medical software sup-
pliers are being approached
to allow the new units to be
transmitted automatically to
desktop software.
Training and further
Information
The International Diabetes
Federation recommends that
self-monitoring of blood glu-
cose should be used only
when individuals with dia-
betes (and/or their care-
givers) and/or their health-
care providers have the
knowledge, skills and will-
ingness to incorporate it and
therapy adjustment into their
diabetes care plan in order
to attain agreed treatment
goals.
The target
range for adults
with diabetes
should still be
individualised ...
However, for most
it will be less than
5 3mrnol/mol
(<7.0%).
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Diabetes educators accred-
ited through the Australian
Diabetes Educators Associa-
tion can help your patients
learn how to use blood glu-
cose meters effectively and
to understand the changes to
the new HbAic reporting
system.
Mr Barker is a credentialled
diabetes educator nurse
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practitioner, Hornsby Ku-ring-
gai Health Service,
Sydney, NSW.
Dr Shephard is director of the
Flinders University International
Centre for Point-of-Care
Testing, Flinders University,
Adelaide, SA.
Mr Goodall is a retired member
of the IFCC HbAic Working
Group 1985-2010.
Ms Obersteller is a
credentialled diabetes educator
nurse practitioner, Northern
Health, Bundoora, Vic.
Dr Jones is a staff specialist in
chemical pathology,
St Vincent's Hospital,
Sydney, NSW.
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